Clinical Trial Update: Thalidomide Combined With Chemotherapy in the Treatment of Relapsed or Refractory Yolk Sac Tumor [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating thalidomide combined with chemotherapy for relapsed or refractory yolk sac tumor and other germ cell tumors has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Germ Cell Tumor
• Yolk Sac Tumor

Drugs mentioned

• Thalidomide (thalidomide)

Snippet

Sponsor: Shandong First Medical University | Conditions: Germ Cell Tumor, Yolk Sac Tumor | Phase 2 | Status: COMPLETED